GPCR News 

Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...

Naggie and Rajagopal Elected Members of American Society for Clinical Investigation

Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...

Ermium Therapeutics has constituted its SAB

AELIS PHARMA launches their IPO for €25 million

InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...

Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...

Carola Weiss joins InterAx Biotech AG as VP Business Development

Sosei Heptares reported its FY2021 financial result and provided an update on operational activities

Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...

Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...

Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

Novo Nordisk moves to strengthen obesity efforts

ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...

Learn more about Neurocrine Biosciences with their new video

Verily links up with Sosei Heptares for GPCR drug discovery

ShouTi Pharma has a brand new website

Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...

Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI